Triggering receptor expressed on myeloid cells-1 (TREM-1) improves host defence in pneumococcal pneumonia

Journal of Pathology

Volumn 233, Issue 4, 2014, Pages 357-367

  Hommes, Tijmen J ^a   Hoogendijk, Arie J ^a   Dessing, Mark C ^a   Van'T Veer, Cornelis ^a   Florquin, Sandrine ^a   Colonna, Marco ^b   De Vos, Alex F ^a   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

innate immunity; macrophages; phagocytosis; pneumococcal pneumonia; TREM 1

Indexed keywords

TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRANULOCYTE; HOST RESISTANCE; INNATE IMMUNITY; LUNG LAVAGE; MACROPHAGE; MALE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

INNATE IMMUNITY; MACROPHAGES; PHAGOCYTOSIS; PNEUMOCOCCAL PNEUMONIA; TREM-1;

ANIMALS; CELL MOVEMENT; CYTOKINES; DISEASE MODELS, ANIMAL; IMMUNITY, INNATE; MACROPHAGES, ALVEOLAR; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; PNEUMONIA, PNEUMOCOCCAL; RECEPTORS, IMMUNOLOGIC; STREPTOCOCCUS PNEUMONIAE;

EID: 84904253195     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4361     Document Type: Article

References (33)

1. van der Poll T, Opal SM,. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 2009; 374: 1543-1556.
2. Mandell LA, Wunderink RG, Anzueto A, et al., Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 (suppl 2): S27-72.
3. Bartlett JG, Dowell SF, Mandell LA, et al., Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000; 31: 347-382.
4. Feldman C., Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. J Lab Clin Med 2004; 143: 269-283.
5. Kawai T, Akira S,. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011; 34: 637-650.
6. Bouchon A, Dietrich J, Colonna M,. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000; 164: 4991-4995.
7. Gibot S, Kolopp-Sarda MN, Bene MC, et al., A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med 2004; 200: 1419-1426.
8. Netea MG, Azam T, Ferwerda G, et al., Triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies the signals induced by the NACHT-LRR (NLR) pattern recognition receptors. J Leukoc Biol 2006; 80: 1454-1461.
9. Angus DC, van der Poll T,. Severe sepsis and septic shock. N Engl J Med 2013; 369: 840-851.
10. Derive M, Massin F, Gibot S,. Triggering receptor expressed on myeloid cells-1 as a new therapeutic target during inflammatory diseases. Self Nonself 2010; 1: 225-230.
11. Bouchon A, Facchetti F, Weigand MA, et al., TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001; 410: 1103-1107.
12. Gibot S, Buonsanti C, Massin F, et al., Modulation of the triggering receptor expressed on the myeloid cell type 1 pathway in murine septic shock. Infect Immun 2006; 74: 2823-2830.
13. Gibot S, Massin F, Marcou M, et al., TREM-1 promotes survival during septic shock in mice. Eur J Immunol 2007; 37: 456-466.
14. Gibot S, Alauzet C, Massin F, et al., Modulation of the triggering receptor expressed on myeloid cells-1 pathway during pneumonia in rats. J Infect Dis 2006; 194: 975-983.
15. Klesney-Tait J, Keck K, Li X, et al., Transepithelial migration of neutrophils into the lung requires TREM-1. J Clin Invest 2013; 123: 138-149.
16. Rijneveld AW, Weijer S, Florquin S, et al., Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide. Blood 2004; 103: 1702-1709.
17. Dessing MC, Florquin S, Paton JC, et al., Toll-like receptor 2 contributes to antibacterial defence against pneumolysin-deficient pneumococci. Cell Microbiol 2008; 10: 237-246.
18. Achouiti A, Vogl T, Urban CF, et al., Myeloid-related protein-14 contributes to protective immunity in Gram-negative pneumonia-derived sepsis. PLoS Pathog 2012; 8: e1002987.
19. Wiersinga WJ, Veer Cvt, Wieland CW, et al., Expression profile and function of triggering receptor expressed on myeloid cells-1 during melioidosis. J Infect Dis 2007; 196: 1707-1716.
20. Van Ziffle JA, Lowell CA,. Neutrophil-specific deletion of Syk kinase results in reduced host defense to bacterial infection. Blood 2009; 114: 4871-4882.
21. Eske K, Breitbach K, Kohler J, et al., Generation of murine bone marrow derived macrophages in a standardised serum-free cell culture system. J Immunol Methods 2009; 342: 13-19.
22. Knapp S, Leemans JC, Florquin S, et al., Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia. Am J Respir Crit Care Med 2003; 167: 171-179.
23. Weijer S, Sewnath ME, de Vos AF, et al., Interleukin-18 facilitates the early antimicrobial host response to Escherichia coli peritonitis. Infect Immun 2003; 71: 5488-5497.
24. Murray PJ, Wynn TA,. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011; 11: 723-737.
25. Lagler H, Sharif O, Haslinger I, et al., TREM-1 activation alters the dynamics of pulmonary IRAK-M expression in vivo and improves host defense during pneumococcal pneumonia. J Immunol 2009; 183: 2027-2036.
26. Hoogerwerf JJ, de Vos AF, van't Veer C, et al., Priming of alveolar macrophages upon instillation of lipopolysaccharide in the human lung. Am J Respir Cell Mol Biol 2010; 42: 349-356.
27. Chung DH, Seaman WE, Daws MR,. Characterization of TREM-3, an activating receptor on mouse macrophages: definition of a family of single Ig domain receptors on mouse chromosome 17. Eur J Immunol 2002; 32: 59-66.
28. van der Poll T, Keogh CV, Buurman WA, et al., Passive immunization against tumor necrosis factor-α impairs host defense during pneumococcal pneumonia in mice. Am J Respir Crit Care Med 1997; 155: 603-608.
29. Rijneveld AW, Florquin S, Branger J, et al., TNFα compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia. J Immunol 2001; 167: 5240-5246.
30. Radsak MP, Salih HR, Rammensee HG, et al., Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival. J Immunol 2004; 172: 4956-4963.
31. Hirst RA, Kadioglu A, O'Callaghan C, et al., The role of pneumolysin in pneumococcal pneumonia and meningitis. Clin Exp Immunol 2004; 138: 195-201.
32. Malley R, Henneke P, Morse SC, et al., Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci USA 2003; 100: 1966-1971.
33. Davis KM, Nakamura S, Weiser JN,. Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice. J Clin Invest 2011; 121: 3666-3676.